To investigate the prevalence of human papillomavirus (HPV) in archival head and neck cancer (HNC) collected from the Tong-Liao area, which is located in east Inner Mongolia, China.
Methods:
The presence of HPV in 54 HNCs and 25 benign biopsies was detected and the sequence variation of the E6 gene in HPV-positive samples was analyzed to determine their lineage/sublineage classification.
Results:
HPV was detected in only 4 out of 54 HNCs and no benign biopsies were found to be HPV-positive. After further p16INK4a immunostaining, only 3 cases of HNC were positive for both HPV and p16INK4a. Phylogenetic analysis of the isolated E6 gene shows that the HPV 16, HPV 31, and HPV 58 isolated in this study belong to lineage A.
Conclusions:
The prevalence of HPV in HNC from this area is very low. The lineage/sublineage classification of the 3 HPV types in HNC in this area is consistent with the previous reported data of HPV lineage distribution in cervical cancer within China.
JemalABrayFCenterMM, et al. Global cancer statistics. CA Cancer J2011;61:69–90.
2.
GillisonMLD’SouzaGWestraW, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst2008;100:407–420.
3.
SturgisEMCinciripiniPM.Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?Ann NY Acad Sci2007;110:1429–1435.
4.
CardesaANadalA.Carcinoma of the head and neck in the HPV era. Acta Dermatovenereol Alp Pannonica Adriat2011;20:161–173.
5.
NdiayeCMenaMAlemanyL, et al. HPV DNA, e6/e7 MRNA, and p16ink4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol2014;15:1319–1331.
6.
LiuBLuZWangP, et al. Prevalence of high-risk human papillomavirus types (HPV-16, HPV-18) and their physical status in primary laryngeal squamous cell carcinoma. Neoplasma2010;57:594–600.
7.
XuYLiuSYiH, et al. Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients. J Med Virol2015;87:281–286.
8.
WeiWShiQGuoF, et al. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncol Rep2012;28:1750–1756.
9.
HuangHZhangBChenW, et al. Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma. Asian Pac J Cancer Prev2012;13:891–896.
10.
XuYLiuSYiH, et al. Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinoma. PLoS One2014;9:e115914.
11.
ManosMWrightDK. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells1989:209–214.
12.
JacobsMVde Roda HusmanAMvan den BruleAJ, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol1995;33:901–905.
KreimerARCliffordGMBoyleP, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev2005;14:467–475.
15.
RibeiroKBLeviJEPawlitaM, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol2011;40:489–502.
16.
NdiayeCAlemanyLDiopY, et al. The role of human papillomavirus in head and neck cancer in Senegal. Infect Agent Cancer2013;8:14.
17.
GuoLYangFYinY, et al. Prevalence of human papillomavirus type-16 in head and neck cancer among the Chinese population: a meta-analysis. Front Oncol2018;8:619.
18.
LuGWangLSunY, et al. Detection of different subtypes of HPV DNA in 57 cases of laryngeal carcinoma in Easter of the Shandong province. J Otolaryngol Ophthalmol Shandong Univ2012;26:16–19.
19.
HeBChenFCaoY, et al. A case control study on the association between HPV infection and oral cancer in Fujian area. J Fujian Med Univ2014;48:100–105.
20.
WangHSunRHuW.Human papillomavirus infection and HRAS, PIK3CA mutations analysis in patients with early laryngeal carcinoma. Cancer Res Clin2014;26:361–365.
21.
AnantharamanDAbedi-ArdekaniBBeachlerDC, et al. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer2017;140:1968–1975.
22.
BolandJMMcPhailEDGarciaJJ, et al. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol2012;25:529–536.
23.
ChanPKLamCWCheungTH, et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern china. J Infect Dis2002;186:696–700.
24.
ShangQWangYFangY, et al. Human papillomavirus type 16 variant analysis of e6, e7, and l1 genes and long control region in cervical carcinomas in patients in northeast China [corrected]. J Clin Microbiol2011;49:2656–2663.
25.
SunMGaoLLiuY, et al. Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in central China. PLoS One2012;7:e36577.
26.
ZhangJWangTHanM, et al. Variation of human papillomavirus 16 in cervical and lung cancers in Sichuan, China. Acta Virol2010;54:247–253.
27.
LiYWangXNiT, et al. Human papillomavirus type 58 genome variations and RNA expression in cervical lesions. J Virol2013;87:9313–9322.
28.
YueYYangHWuK, et al. Genetic variability in l1 and l2 genes of HPV-16 and HPV-58 in southwest China. PLoS One2013;8:e55204.
29.
LiuJHLuZTWangGL, et al. Variations of human papillomavirus type 58 e6, e7, l1 genes and long control region in strains from women with cervical lesions in Liaoning province, China. Infect Genet Evol2012;12:1466–1472.
30.
LiuMHeZXiL, et al. The distribution and common amino acid polymorphisms of human papillomavirus (HPV)-31 variants in 2700 women from northern China. PLoS One2014;9:e99141.
31.
HeJZhaoPChenWQ.Chinese Cancer Registry Annual Report.Beijing:Military Medical Science Press;2012.
